Lista de obras -

A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.

artículo científico publicado en 2018

A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine

artículo científico publicado en 2007

A window into the brain: an in vivo study of the retina in schizophrenia using optical coherence tomography

artículo científico publicado en 2012

Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial.

artículo científico publicado en 2018

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial

artículo científico publicado en 2016

Antipsychotic long-acting injections: prescribing practice in the UK.

artículo científico publicado en 2009

Antipsychotic polypharmacy in schizophrenia: benefits and risks

artículo científico publicado en 2011

Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services

artículo científico

Are socioenvironmental factors associated with psychotic symptoms in people with first-episode psychosis? A cross-sectional study of a West London clinical sample

artículo científico publicado en 2019

Assessment of adverse effects in clinical studies of antipsychotic medication: survey of methods used.

artículo científico publicado en 2010

Attitudes to atypical and conventional antipsychotic drug treatment in clinicians participating in the cutlass study

artículo científico publicado en 2005

Authors' reply

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

artículo científico publicado en 2007

Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial

artículo científico publicado en 2018

Cognitive heterogeneity in first-episode schizophrenia.

artículo científico publicado en 2005

Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT

article

Comorbid substance use and age at onset of schizophrenia

artículo científico publicado en 2006

Deconstructing Depression and negative symptoms of Schizophrenia; differential and longitudinal immune correlates, and response to Minocycline treatment

artículo científico publicado en 2020

Development and clinimetric assessment of a nurse-administered screening tool for movement disorders in psychosis

artículo científico publicado en 2018

Do antidepressants improve negative symptoms in schizophrenia?

artículo científico publicado en 2011

Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia

artículo científico publicado en 2008

Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes

artículo científico publicado en 2013

Effects of cannabis use on outcomes of psychotic disorders: systematic review

artículo científico publicado en 2008

Evaluating the clinical and cost effectiveness of a behaviour change intervention for lowering cardiovascular disease risk for people with severe mental illnesses in primary care (PRIMROSE study): study protocol for a cluster randomised controlled t

artículo científico publicado en 2016

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

scientific article published on 12 December 2019

Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs

artículo científico publicado en 2012

First- vs Second-Generation Antipsychotic Drugs in Schizophrenia—Reply

Gaze strategies during planning in first-episode psychosis

artículo científico publicado en 2007

Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial

artículo científico publicado en 2012

IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis

artículo científico publicado en 2008

IQ trajectory, cognitive reserve, and clinical outcome following a first episode of psychosis: a 3-year longitudinal study

artículo científico publicado en 2009

Improving prescribing practice in psychiatry: the experience of the Prescribing Observatory for Mental Health (POMH-UK).

artículo científico publicado en 2011

Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia

artículo científico publicado en 2022

Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)

artículo científico publicado en 2019

LARGE EFFECT OF BASELINE TREATMENT WITH LONG ACTING ANTIPSYCHOTIC DRUGS ON RANDOMIZED TREATMENT OUTCOMES

Lithium in bipolar and other affective disorders: prescribing practice in the UK.

artículo científico publicado en 2010

M11. Long-Term Antidepressant Treatment for Negative Symptoms in Schizophrenia: The ACTIONS Study.

artículo científico publicado en 2017

Medicines Reconciliation on Admission to Inpatient Psychiatric Care: Findings from a UK Quality Improvement Programme.

scientific article published on August 2011

Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT

More haste less speed: A meta-analysis of thinking latencies during planning in people with psychosis

artículo científico publicado en 2017

Movement Disorders Associated With Antipsychotic Medication in People With Schizophrenia: An Overview of Cochrane Reviews and Meta-Analysis.

artículo científico publicado en 2018

Nocturnal enuresis with antipsychotic medication

artículo científico publicado en 2012

Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1).

artículo científico publicado en 2013

Prescribing and monitoring lithium therapy: summary of a safety report from the National Patient Safety Agency

artículo científico publicado el 19 de noviembre de 2010

Prescribing for moderate or severe unipolar depression in patients under the long-term care of UK adult mental health services

artículo científico publicado en 2020

Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.

artículo científico publicado en 2007

Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT

Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)

artículo científico publicado en 2019

Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia

artículo científico publicado en 2006

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

artículo científico publicado en 2006

Relationship between insight, cognitive function, social function and symptomatology in schizophrenia: the West London first episode study.

artículo científico publicado en 2006

Role of the prescribing observatory for mental health

artículo científico publicado en 2012

SU11. Amisulpride Augmentation of Clozapine for Treatment-Refractory Schizophrenia: The AMICUS Study.

artículo científico publicado en 2017

T46. TARGETING THE IMMUNE SYSTEM TO TREAT DEPRESSION AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA.

artículo científico publicado en 2018

T86. COGNITIVE SUBTYPES IN FIRST-EPISODE PSYCHOSIS: AN EMPIRICAL LONGITUDINAL STUDY OF RELATIONSHIP TO COGNITIVE, SYMPTOM AND FUNCTIONAL OUTCOMES.

artículo científico publicado en 2018

The ANNSERS (Antipsychotic Non-Neurological Side Effects Rating Scale): Validation of Sexual Side-Effect Measurement

scientific article published on August 2011

The Effect of Cannabis Use and Cognitive Reserve on Age at Onset and Psychosis Outcomes in First-Episode Schizophrenia ⬇️

artículo científico publicado el 9 de marzo de 2011

The MATISSE study: a randomised trial of group art therapy for people with schizophrenia

artículo científico publicado en 2010

The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial

artículo científico publicado en 2015

The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial

scientific article published on 12 October 2018

The component structure of the scales for the assessment of positive and negative symptoms in first-episode psychosis and its dependence on variations in analytic methods

artículo científico publicado en 2018

The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services

scientific article published on 06 August 2020

The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome

artículo científico publicado en 2008

The relationship between negative symptoms and depression in schizophrenia: a systematic review.

artículo científico publicado en 2018

The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services

artículo científico publicado en 2015

Undertaking clinical audit, with reference to a Prescribing Observatory for Mental Health audit of lithium monitoring

artículo científico publicado en 2014

Lista de obras de

A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.

A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine

A window into the brain: an in vivo study of the retina in schizophrenia using optical coherence tomography

Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial.

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial

Antipsychotic long-acting injections: prescribing practice in the UK.

Antipsychotic polypharmacy in schizophrenia: benefits and risks

Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services

Are socioenvironmental factors associated with psychotic symptoms in people with first-episode psychosis? A cross-sectional study of a West London clinical sample

Assessment of adverse effects in clinical studies of antipsychotic medication: survey of methods used.

Attitudes to atypical and conventional antipsychotic drug treatment in clinicians participating in the cutlass study

Authors' reply

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial

Cognitive heterogeneity in first-episode schizophrenia.

Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT

Comorbid substance use and age at onset of schizophrenia

Deconstructing Depression and negative symptoms of Schizophrenia; differential and longitudinal immune correlates, and response to Minocycline treatment

Development and clinimetric assessment of a nurse-administered screening tool for movement disorders in psychosis

Do antidepressants improve negative symptoms in schizophrenia?

Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia

Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes

Effects of cannabis use on outcomes of psychotic disorders: systematic review

Evaluating the clinical and cost effectiveness of a behaviour change intervention for lowering cardiovascular disease risk for people with severe mental illnesses in primary care (PRIMROSE study): study protocol for a cluster randomised controlled t

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs

First- vs Second-Generation Antipsychotic Drugs in Schizophrenia—Reply

Gaze strategies during planning in first-episode psychosis

Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial

IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis

IQ trajectory, cognitive reserve, and clinical outcome following a first episode of psychosis: a 3-year longitudinal study

Improving prescribing practice in psychiatry: the experience of the Prescribing Observatory for Mental Health (POMH-UK).

Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia

Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)

LARGE EFFECT OF BASELINE TREATMENT WITH LONG ACTING ANTIPSYCHOTIC DRUGS ON RANDOMIZED TREATMENT OUTCOMES

Lithium in bipolar and other affective disorders: prescribing practice in the UK.

M11. Long-Term Antidepressant Treatment for Negative Symptoms in Schizophrenia: The ACTIONS Study.

Medicines Reconciliation on Admission to Inpatient Psychiatric Care: Findings from a UK Quality Improvement Programme.

Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT

More haste less speed: A meta-analysis of thinking latencies during planning in people with psychosis

Movement Disorders Associated With Antipsychotic Medication in People With Schizophrenia: An Overview of Cochrane Reviews and Meta-Analysis.

Nocturnal enuresis with antipsychotic medication

Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1).

Prescribing and monitoring lithium therapy: summary of a safety report from the National Patient Safety Agency

Prescribing for moderate or severe unipolar depression in patients under the long-term care of UK adult mental health services

Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.

Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT

Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)

Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

Relationship between insight, cognitive function, social function and symptomatology in schizophrenia: the West London first episode study.

Role of the prescribing observatory for mental health

SU11. Amisulpride Augmentation of Clozapine for Treatment-Refractory Schizophrenia: The AMICUS Study.

T46. TARGETING THE IMMUNE SYSTEM TO TREAT DEPRESSION AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA.

T86. COGNITIVE SUBTYPES IN FIRST-EPISODE PSYCHOSIS: AN EMPIRICAL LONGITUDINAL STUDY OF RELATIONSHIP TO COGNITIVE, SYMPTOM AND FUNCTIONAL OUTCOMES.

The ANNSERS (Antipsychotic Non-Neurological Side Effects Rating Scale): Validation of Sexual Side-Effect Measurement

The Effect of Cannabis Use and Cognitive Reserve on Age at Onset and Psychosis Outcomes in First-Episode Schizophrenia ⬇️

The MATISSE study: a randomised trial of group art therapy for people with schizophrenia

The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial

The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial

The component structure of the scales for the assessment of positive and negative symptoms in first-episode psychosis and its dependence on variations in analytic methods

The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services

The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome

The relationship between negative symptoms and depression in schizophrenia: a systematic review.

The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services

Undertaking clinical audit, with reference to a Prescribing Observatory for Mental Health audit of lithium monitoring